mFluiDX

Enabling molecular detection anywhere

Company Details

The mFluiDx platform is fully autonomous, smart-phone enabled unit ideal for on-site testing. Also, Injection molding allows mass production of chips at cost 1000 times lower than PCR. In addition, sothermal nucleic acid amplification allows sensitivity comparable to PCR. So, with quick and accurate results the platform allows real-time tracking of outbreak, conveying important information during most crucial times of outbreak.

Company People

Charlie Yeh

Charlie Yeh
CEO & Co-Founder

You might also be interested in

No Offer, Solicitation, Advice, or Recommendation

Except to the extent expressly set forth in materials as may be provided through a password protected area on the SOSV website (the "Materials"), or as otherwise expressly specified by SOSV in writing, nothing on the SOSV website or on any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, is intended to constitute (i) an offer, or solicitation of an offer, to purchase or sell any security, other asset or service, (ii) investment advice or an offer to provide such advice, or (iii) a basis for making any investment decision. Except as expressly stated by SOSV in writing, neither the SOSV website or any platform or other communications medium owned, operated or otherwise by or on behalf of SOSV, nor any of the Materials make any effort to present a comprehensive or balanced description of SOSV or its investment activities. Please note the SOSV Communication Policy available here.